Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

PD-L1 NEGATIVE

Clinical trials for PD-L1 NEGATIVE explained in plain language.

Never miss a new study

Get alerted when new PD-L1 NEGATIVE trials appear

Sign up with your email to follow new studies for PD-L1 NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1
Sort by
  • New hope for Hard-to-Treat breast cancer: drug combo trial launches

    Disease control Recruiting now

    This study tests whether adding pembrolizumab to sacituzumab govitecan helps control metastatic triple-negative breast cancer that is PD-L1-negative. About 110 adults with advanced TNBC will be randomly assigned to receive either the combination or sacituzumab alone. The goal is …

    Matched conditions: PD-L1 NEGATIVE

    Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

    Last updated Jun 27, 2026 12:24 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space